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Abstract Understanding molecular recognition is one
major requirement for drug discovery and design. Physi-
cochemical and shape complementarity between two
binding partners is the driving force during complex for-
mation. In this study, the impact of shape within this
process is analyzed. Protein binding pockets and co-crys-
tallized ligands are represented by normalized principal
moments of inertia ratios (NPRs). The corresponding
descriptor space is triangular, with its corners occupied by
spherical, discoid, and elongated shapes. An analysis of a
selected set of sc-PDB complexes suggests that pockets and
bound ligands avoid spherical shapes, which are, however,
prevalent in small unoccupied pockets. Furthermore, a
direct shape comparison confirms previous studies that on
average only one third of a pocket is filled by its bound
ligand, supplemented by a 50 % subpocket coverage. In
this study, we found that shape complementary is expres-
sed by low pairwise shape distances in NPR space, short
distances between the centers-of-mass, and small devia-
tions in the angle between the first principal ellipsoid axes.
Furthermore, it is assessed how different binding pocket
parameters are related to bioactivity and binding efficiency
of the co-crystallized ligand. In addition, the performance
of different shape and size parameters of pockets and
ligands is evaluated in a virtual screening scenario per-
formed on four representative targets.
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Introduction
The identification of a small molecule that is able to
modulate or block specific protein functions is one major
goal in pharmaceutical research. Shape complementarity
between ligand and its binding site is a condition for
molecular recognition, but not alone sufficient. The binding
of a small molecule to a receptor requires additional
complementarity of electronic features [1]. However, even
if electrostatic attraction can be significant over large dis-
tances, steric repulsion can counter any such interaction
[2]. Therefore, one might rank the three properties size,
shape, and electrostatics in this exact order: A molecule
needs to have an appropriate size to enter the binding
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cavity, it needs to be able to exhibit a comparable shape
preventing clashes with the protein and to ensure optimal
positioning of its functional groups in the molecular
context to finally establish the necessary electrostatic
complementarity. Many computational drug discovery
approaches including molecular modeling and docking are
based on a correct representation of these mechanisms and
benefit from a better understanding of the recognition
driving forces. Several computational studies have already
been pursued to identify the importance of shape and
chemical complementary between two binding partners
[3–6]. Morris et al. [7], e.g., claimed that a large proportion
of recognition potency resides in a tight shape fit between the
two reaction partners. Many approaches exist that describe
the molecular shape of small molecules in different granu-
larities [8–10]. These abstractions are often used to virtually
screen through large compound collections, e.g., by calcu-
lating the similarity between a reference compound and other
chemical entities. A comprehensive perspective on the use of
molecular shape approaches in medicinal chemistry has been
published by Nicholls et al. [6].
Shape comparison methods, such as ROCS [11] and
SQW [12], calculate a similarity value based on 3D coor-
dinates between a query ligand and a database [9]. ROCS,
e.g., computes a volume overlap of the molecules being
compared and has been used successfully in many
screening experiments. Another such method is the Ultra
Fast Shape comparison (USR) [13], where molecules are
compared based on the moments of four distributions of
atomic distances. Due to its simple calculation, this method
outperforms other shape descriptions with respect to
computing time requirements. Another prominent approach
is using Normalized Principal Moments of Inertia Ratios
(NPRs) [14]. Besides not requiring a superposition of the
input molecules, NPRs are independent of size, show low
computational complexity, and allow the projection onto a
finite triangular space that can easily be visualized. Based
on the position of a data point in this NPR space, it can be
assigned as being rod-, disc-, or sphere-like. In the context
of multiple-scaffold versus single-scaffold combinatorial
compound libraries, the idea of a pocket-shape focused
space was introduced [14]. Akritopoulu-Zanze et al. [15]
used NPRs to compare distributions of rule-of-five com-
pliant compounds from the MDDR database and the cor-
porate compound collection of Abbott. A drug-like shape
space was derived and used to actively bias compound
selection for HTS screening as well as for compound
acquisition. In a recent study, the shape distribution in NPR
space of small molecules originating from various large
data sets was analyzed [16]. Globular ligand shapes were
very rarely observed over all data sets.
Equally to the analysis of small molecular shapes, sev-
eral studies explore the shapes of protein binding pockets.
Already in 1998, a study of the anatomy of protein pockets
revealed that the size and shape space of ligand binding
sites is manifold [17]. Found shapes spread from simple
spheres to more complicated shapes like curved grooves of
several interconnected subpockets. Sonavane and Chak-
rabarti [18] describe the shape of a pocket by an estimated
surface to volume ratio of a cavity relative to that of a
sphere having the same volume as the cavity. They report a
large number of globular pockets, but almost exclusively of
small size. Weisel et al. [19] provide an overview about
pocket architectures in a selected set of 623 co-crystallized
complexes. In their work, they identify recurrent pocket
topology patterns with the majority being elongated and
containing one or more subbranches.
In addition to performing ligand-based shape compari-
sons between reference ligands and potential active mole-
cules, if available, drug discovery projects can heavily
benefit from structural information of the targeted protein.
Various docking tools are available to algorithmically fit
small molecules into the protein context and to assess their
complementarity by scoring potential interactions. As this
approach is computationally expensive, especially in the
lead identification phase, a reduction of the search space
through wise filtering can be of great benefit. Here, a
detailed comparison of ligand and pocket sizes and shapes
could be helpful as a first filtering step with the aim to
reduce the size of the initial compound set to dock. In this
context, some recent effort towards a direct comparison of
ligand and pocket shape was promoted. Spherical har-
monics have been investigated as shape representation in a
work by Kahraman et al. [4], revealing that binding
pockets are more flexible in their shapes than their
respective ligands. Furthermore, the study showed that
binding pocket and ligand volumes differ on average by a
factor of three. Pe´rot et al. [20] observed in a case study on
56 complexes of the Astex set a correlation between pocket
and ligand volumes and highlighted several cases of tight
shape complementarity.
In this work, we present an analysis of ligand and pocket
shapes using selected data from the sc-PDB [21]. Pockets
and subpockets are predicted with DoGSite [22], followed by
the calculation of shape properties [23]. Ligand and pocket
shapes are approximated by ellipsoidal and moment of
inertia main axes. The present article consists of three
evaluation parts: First, an extensive analysis on pairwise
combinations of binding pocket and corresponding ligand
with respect to their shapes is performed. In accordance to
the lack of globular ligand shapes in nature [16], globular
ligand binding sites are found to be underrepresented. Shapes
of occupied binding pockets are generally observed to be
more globular than their containing ligand. When consider-
ing all cavities detected by DoGSite—including those
without bound ligand and disabling a minimum volume
512 J Comput Aided Mol Des (2013) 27:511–524
123
threshold for predicted pockets—globular shapes are
detected predominantly for small pockets. Furthermore, the
respective ligand and pocket shape overlap is analyzed;
pockets exhibit an average coverage of one third, while
subpockets are on average covered by one half. The second
part of this article addresses the relation between shape
complementarity and bioactivity. In addition, it is analyzed
whether information about the binding pocket of a particular
target can be used to give an insight into the maximal
achievable efficiency of a novel compound binding to this
pocket. Finally, we analyze the performance of shape and
size parameters retrieved from binding pocket and co-crys-
tallized ligand in a virtual screening context. It is assessed if
these parameters can be used to filter out compounds prior to
screening, while preserving highly ranked actives.
Data preparation
Shape analysis data set
Version 2011 of the sc-PDB [21] is used for the shape com-
parison study. This version contains 9,877 entries, for 9,867 of
which the original entry could be retrieved from the PDB [24].
Subsequently, several quality filters for both, small molecule
structures and protein crystal structures, are implemented
(Fig. 1). Ligand entries are checked for bad valences, inor-
ganic elements, and for their size as function of their number
of heavy atoms. Small molecule conformations, as given by
the sc-PDB data, are minimized using the MMFF94x force
field [25] implemented in MOE 2011.10. The energy differ-
ence of the sc-PDB conformation to the minimal energy
conformation is calculated and used as a filter criterion to
reject compounds in high energy conformations. These cri-
teria lead to a final data set of 7,751 ligands.
Retrieved crystal structure data are analyzed using the
Diffraction Precision Index (DPI) [26] calculator devel-
oped by Vainio et al. [27]. Entries are kept if the following
criteria are fulfilled: resolution B 2.5 A˚, Rfree B 0.3, and
DPI B 0.5 A˚. The intersection between the retained 7,258
protein structures and the 7,751 ligand entries yields the
final 5,755 protein-ligand pairs.
Subsequently, DoGSite [22] is used to identify binding
pockets of each ligand. Ligands may be only partially
contained in the predicted pocket with parts of it reaching
into the solvent or into a neighboring pocket. As such
examples bear a potential bias for the comparison between
ligand and pocket shape, only pockets with a ligand cov-
erage of 100 % are considered for this analysis, i.e. the
entire ligand occupies only one pocket. In total, 2,363
pocket-ligand pairs fulfill this criterion and are kept for the
following analyses.
Bioactivity data
Information on experimental ligand bioactivity is retrieved
from the PDBBind database [28]. Only entries annotated as
‘‘high quality’’ are considered for this analysis. Entries are
matched with data points of the ligand/pocket sc-PDB data
set by using the PDB identifier. Overall, 355 experimental
values could be matched to ligand/pocket pairs. The data
are categorized into three activity classes: highly active:
pKi or pKd C 8.5 (83 entries), moderately active: pKi or
pKd C 6.5 and\ 8.5 (120 entries), and weakly active: pKi
or pKd \ 6.5 (152 entries).
Virtual screening data set
Version 13 of the ChEMBL database [29] is used as basis
for the docking performance experiments. Data points are
Fig. 1 Overview of the sc-PDB
data preparation
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selected according to the following criteria: all compounds
with annotated assay data in IC50, EC50, Ki, or Kd, as
standardized by ChEMBL curators, are selected. In order to
keep only small molecules, compounds with a molecular
weight C 1,000 Da are filtered out. Entries are kept if a
curator of the ChEMBL database annotated the observed
effect in a particular assay as directly related to an inter-
action with a particular molecularly defined target (confi-
dence level 9). In case of obvious errors in their annotated
bioactivity data, data points are manually removed. Omega
2.4.6 [30] is used to calculate a minimal energy conformer
for each molecule. Compounds are rejected from the data
set if stereo-chemistry is not properly annotated. In total,
123,539 data points are used for the following analysis.
Data points are considered ‘‘active’’ for the analyzed target
if a bioactivity below 3.2 lM had been reported. If their
annotated bioactivity was above 10 lM or had not been
reported with an activity against the target of interest, they
were considered ‘‘inactive’’. Note that it cannot be pre-
sumed that all of these ‘‘inactives’’ are true negatives. Once
tested against the respective target, it is possible that a
wrongly assumed inactive may defect to the active set
impacting the perceived screening results. The docking
experiments are performed on four targets (see Table 1),
with the intent to broadly sample the binding pocket NPR
shape space (Fig. 11). Additionally, the selected targets are
required to hold a sufficient number of measured data
points in the extracted ChEMBL data.
Material and methods
Pocket calculation
Potential pockets—solvent exposed and buried ones—are
detected on the protein surface using DoGSite [22]. The
method maps the protein atoms onto a 3D grid with a
default spacing of 0.4 A˚. Grid points are labeled as occu-
pied if they are covered by a protein atom; otherwise as
free. A difference of Gaussians (DoG) filter is applied to
find cavities on the protein surface. Grid points with cal-
culated DoG values below a defined threshold are clustered
to subpockets. Subsequently, neighboring subpockets can
be merged to pockets. Per default, only pockets and
subpockets with volumes larger than 100 and 50 A˚3,
respectively, are considered. In this work, we lowered this
threshold to 20 A˚3 (subpockets 10 A˚3, respectively) to be
included in the pocket shape analysis; the number of
pockets per protein was limited to 100.
Note that ligand location is not taken into account for
pocket detection. Nevertheless, a ligand can be provided to
select the pocket of interest from the set of predicted
pockets. In this case, the overlap between ligand and
pocket can be calculated, based on the volume overlap of
ligand atoms and pocket grid points, resulting in a value
between zero and 100 % for pocket and ligand coverage,
respectively.
Since subpockets provide a more fine-granular descrip-
tion of the binding site, the experiments in this study are
performed on the subpocket level. To simplify the
nomenclature throughout this study, the term pocket has
been used to signify subpockets, except when both are
described in the same context.
Descriptor calculation
Several shape and physicochemical features can be calcu-
lated for the detected pockets [23]. In this study, we focus
on shape and size, i.e. volume, ellipsoidal shape, and
moments of inertia. The discrete pocket volume is calcu-
lated by multiplying the number of pocket grid points with
the cubic grid spacing. Pocket shape can be represented by
ellipsoidal main axes and principal moments of inertia
(PMIs). For both representations, pocket grid points are
used and weighted with 1 in the calculation. The ellipsoidal
pocket description is computed by determining the
covariance matrix over all pocket grid points and identi-
fying the corresponding eigenvalues and -vectors. Simi-
larly, PMIs are calculated by a diagonalization of the
moment of inertia tensor.
For each ligand the bioactive conformation as reported
in the sc-PDB data is chosen. In order to treat protein
pockets and corresponding ligands as similar as possible,
the atomic weight of each ligand heavy atom is likewise
replaced with 1 in the calculation of the inertial moments.
Hence, ellipsoids and moments of inertia are calculated
based on all ligand heavy atom centers. Hydrogen atoms
are not taken into account.
Table 1 Protein crystal
structures selected for the
virtual screening experiments
and their respective active and
inactive counts
Target PDB Actives (% total) Inactives
Mitogen-activated protein kinase 14 (p38) 3hrb 1,025 (0.83) 122,514
Androgen receptor (AR) 3g0w 423 (0.34) 123,116
Vascular endothelial growth factor II (VEGFR2) 2qu6 1,328 (1.07) 122,211
Proto-oncogene serine/threonine-protein kinase (PIM1) 3cy3 144 (0.12) 123,395
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Normalized principal moment of inertia ratios (NPRs)
Starting from a 3D structure described by either pocket grid
points or molecule atoms, the three PMIs are computed.
The NPR descriptor is then calculated by sorting the
resulting values I11, I22, and I33 in ascending order and
dividing the two smaller values by the largest. This causes
a normalization that eliminates size information and rep-
resents one of the major differences in comparison to other
molecular shape descriptors that often intrinsically include
a description of size. The NPR descriptor can be visualized
in a finite, triangular shape space whose corners are rep-
resenting the three geometrical objects rod, disc, and
sphere (Fig. 2). To directly compare the shape character of
ligands and pockets, NPR descriptors can be translated into
a ternary system describing globularity, disc-, and rod-
likeness. Sphericity can be expressed by (npr1 ? npr2 - 1).
Likewise, rod-likeness can be defined as (npr2 - npr1) and
disc-likeness as (2 - 2 * npr2), respectively.
The triangular NPR descriptor space is isosceles not
equilateral, i.e. only two of the sides are of equal length.
For the calculation of distances in this space it is therefore
required to transform the descriptor space into an equilat-
eral triangle. This is achieved by an a priori translation of
npr2 to npr
0
2 ¼
ﬃﬃﬃ
3
p  npr2 þ ð1 
ﬃﬃﬃ
3
p Þ: The pairwise shape
distance between two objects A and B is then calculated by
the Euclidean distance between the two points
(npr1,A0 npr
0
2;A) and (npr1,B0 npr
0
2;B). Due to the underlying
finite triangular space, the maximal distance between two
points is limited to a value of one.
Screening experiments
Glide HTVS docking is performed using the Maestro
software 9.3 of Schroedinger [31]. All protein structures
are treated with the default Glide 5.8 settings. Water
molecules are removed and hydrogen bonding networks are
optimized before grid generation of the receptor by using
the Protein Preparation wizard [32]. The binding site is
defined by the co-crystallized ligand. Finally, prior to
docking, all small molecules from the extracted ChEMBL
data are prepared using LigPrep 2.5 and screened with
Glide 5.8. Compounds are sorted by ascending docking
score, and the best scoring pose is kept for further
enrichment analysis. If a compound could not be docked, it
is appended at the end of the sorted compound list.
Results and discussion
Pocket shape distribution
In a first analysis, pocket and ligand shapes are directly
compared with respect to their distributions in NPR shape
space. To do so, the pocket space has previously been
restricted to pockets binding a known ligand and exhibiting
a volume larger than the predefined cut-off. Due to the size
independence of the NPR descriptor, shapes of all kinds of
small molecules and binding pockets can be directly
compared to each other. The distribution of pocket and
corresponding ligands from the 2,363 sc-PDB entries is
illustrated in Fig. 3.
Descriptor values for binding pockets do not occupy the
western axis of the NPR shape space. While small mole-
cule conformations can be truly flat (e.g., a ligand with
conjugated aromatic system), this cannot hold for binding
pockets, as this contradicts the definition of a binding site
spanning a volume large enough to hold a ligand. The
majority of data points of both distributions are located in
the upper left corner of the NPR triangle, representing rod-
like shapes. The ligand shape distribution of the sc-PDB
data set exhibits a characteristic similar to what has been
observed for various small molecule data sets of different
origins [16]. Similarly, here, no truly globular pockets are
observed. While it is difficult to fully explain this behavior,
one can speculate about potential contributing factors.
First, protein binding pockets and their natural ligands co-
evolve. In this context, spherical symmetry of both—
pocket and ligand—is a very expensive property to pre-
serve without obvious advantages. Second, truly spherical
binding pockets have to be closed on all sides and would
need to provide a sort of entry mechanism for their ligands.
Such mechanisms are known, for example in the HIV-1
protease, but not common. Third, enzymes in particularFig. 2 Overview of the triangular NPR shape space
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need to incorporate not only the substrate but any reaction
partner, transition state and product(s). The lack of sym-
metry across these requirements further decreases the
likelihood for globular binding sites.
The distributions show that binding pockets tend to be
slightly more globular than their ligands (Fig. 3). For a
more detailed analysis, we investigate the shape difference
between corresponding pocket and ligand pairs. Spherical
difference, e.g, is calculated as ligand sphericity minus
pocket sphericity in percent (for details see methods sec-
tion). Figure 4 illustrates the pairwise sphere, rod, and disc
differences for pairs of ligands and pockets. A difference of
zero indicates that pocket and ligand have the same shape
character. The distributions within the rod- and disc-like-
ness difference plots are shifted to the right (Mean (stan-
dard error of the mean (SEM)): 0.05 (0.001), and
0.03 (0.001), respectively), while the sphericity peak is
shifted to the left (Mean (SEM): -0.08 (0.002). These
differences underline the slightly more globular shape
character of pockets also on the pairwise level. Only in rare
cases, large jumps in NPR space, e.g., rod-like pocket with
a discoid ligand, are observed, i.e., distances larger than 0.4
are found in 11.38, 1.18, and 10.16 % of the cases for rod-
likeness, sphericity, and disc-likeness, respectively.
In a subsequent study, the full set of detectable pockets
is investigated (restricted to a maximum of 100 pockets per
structure). For this purpose, the shape of all predicted
pockets—ligand-bound or empty—down to a volume of 10
A˚3 is calculated. In contrast to the previously shown
ligand-bound pocket shape distribution (Fig. 3), a nearly
complete coverage of the NPR shape space can be
observed (Fig. 5, left). Interestingly, contrarily to the
analysis of occupied pockets, here, the shape distribution
center is shifted towards the globular region of the shape
space. Furthermore, amongst all detected pockets of a
protein, small pockets are observed significantly more
often than larger ones (Fig. 5, right).
In order to analyze the dependence of pocket size and
shape, the same analysis is repeated for volume ranges
encoded by 20 A˚3 bins. The results demonstrate the loss of
globularity with increasing pocket volume (Fig. 6). Up to
volumes around 100 A˚3 the distribution is dominated by
globular pocket shapes. Larger pockets tend to possess a
more rod-like shape, expressed by the shift of the shape
distribution center towards the upper left corner of the NPR
triangle.
The dominance of sphere-like pockets has been
described previously in the work of Sonavane and Chak-
rabarti [18]. Furthermore, Pe´rot et al. found in a case study
of 56 Astex complexes that small pockets are the least
compact ones and tend to be rougher, more spherical, and
more polar [20]. Two reasons may contribute to this
observation: First, frequently encountered ligands of that
size are in fact spherical (Na?, K?, NH4
?, Cl-, SO4
-) or
pseudo-spherical (H2O without orientation preference).
Second, unoccupied binding pockets represent empty space
in the protein that is energetically unfavourable. As the
sphere has the smallest surface area for a given volume,
this shape should be adopted in order to minimize physi-
cally unfavourable interactions.
When we split the ligand shape distribution by molec-
ular weight in bins of 100 Da, up to a maximum of 800 Da,
these ligand distributions do not exhibit a similar behavior
than what has been perceived for protein pockets (data not
shown). If any, a slight trend of medium sized ligands
towards a more globular shape can be observed.
When comparing ligand and detected pocket shapes,
two aspects have to be considered: a) the noise introduced
by the pocket boundary definition in the pocket prediction
step, and b) the degree to which the analyzed pockets are
filled by their ligands. As described in the data preparation
section, we have restricted the sc-PDB pocket/ligand shape
analysis to pairs for which the ligand is completely con-
tained in the predicted pocket and neglect cases in which
Fig. 3 Shape distribution in
NPR space of binding pockets
and their respective ligands.
Color code shows the maximal
number of data points per cell
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parts of the molecule are located outside the identified
pocket. However, the analysis, so far, has not taken pocket
coverage into account. Thus, molecules can be much
smaller than their complementary binding pocket and
occupy only a small part of it. Therefore, the shape
behavior in dependence of pocket coverage, split into 5
bins of equal size, is analyzed. In this experiment, pocket
and subpocket based performance is regarded explicitly.
When considering pockets, a clear peak is detected at the
20–40 % coverage bin, indicating that a ‘‘golden ratio’’
between ligand and pocket volume is prevalent in the data
set (Fig. 7).
This confirms the findings by Kahraman et al. [4] on 100
binding sites of 9 frequent ligands that generally only one
third of the pocket is covered by the ligand. Also, Pe´rot
et al. [20] stated that pockets generally tend to bind smaller
ligands. Nevertheless, analyzing the subpocket-based
behavior, coverages between 40 and 60 % are preferen-
tially observed. The tighter pocket boundary definition of
subpockets allows for a more fine-granular analysis and
indicates a higher shape complementary than previously
found.
The analysis of pairwise distances between ligand and
pocket shapes as a function of pocket coverage reveals that
ligand/pocket pairs are more similar in shape at higher
coverage values (Fig. 8a). For pairs with coverages
between 80 and 100 %, the distance in NPR space is on
average 0.15, compared to a baseline distance of 0.24
derived from all ligand shapes against all pocket shapes.
In addition to shape complementarity, the ligand’s
location and orientation in the pocket is analyzed. In
Fig. 8b the centers-of-mass distances of pockets and
ligands are compared with respect to coverage. Under-
standably, the distance of the centers-of-mass diminishes
with increasing pocket coverage.
The mean distance for poorly covered pockets lies at
7.13 A˚, while the number decreases to 0.75 A˚ for perfectly
overlaying volumes. To quantify the orientation of ligand
and pocket to each other, the angle deviation between the
respective largest ellipsoidal main axes is calculated.
Again, angle deviations are analyzed with respect to pocket
coverage, yielding the conclusion that ellipsoidal align-
ment increases with pocket coverage. Figure 8c illustrates
that the median angle of pockets covered to 40–60 % lies at
28.79 and drops to 9.66 for almost completely covered
pockets. For all three discussed parameters, a clear gliding
correlation with increasing pocket coverage is observed.
Throughout these studies, a few outliers have been
observed, e.g., large center-of-mass distances or angle
deviations. These cases may originate from the pocket
prediction step, as large proteins, multimers, or generally
the large variety in binding site space make pocket detec-
tion with accurate boundary definitions difficult.
Ligand binding demands a decent amount of congruence
between the binding partners. Within this analysis, we
found that this required shape complementary can gener-
ally be quantified by a subpocket coverage above 50 %, a
shape distance in NPR space lower than 0.2, a center-of-
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Fig. 4 Pairwise pocket/ligand distance distributions for the three parameters: rod-likeness, sphericity, and disc-likeness, respectivly. Difference
values are calculated by subtracting pocket values from ligand values
Fig. 5 NPR shape distribution of all pockets detected by DoGSite
(with disabled 100 A˚3 volume threshold). Color code shows the
maximal number of data points per cell. Histogram depicts the
volume distribution of these pockets
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mass distance lower than 2.4 A˚ and a main axis angle
deviation below 29.
Bioactivity, ligand efficiency, and pocket parameters
A popular assumption in drug design is that binding affinity
is driven by shape complementarity of the ligand with the
protein [7], as the geometrical fit is a prerequisite of
binding. Matching pharmacophoric features within appro-
priate distance and correct directionality, as well as angles
of established hydrogen bonds, are other important driving
factors for molecular recognition. The relative importance
of electrostatic complementarity vs. shape complementarity
remains an open question. To understand to which degree
shape complementarity alone is responsible for activity, the
correlation between bioactivity, as extracted from the
PDBbind database for 355 examples, and different pocket
parameters is assessed in this study (Table 2). While no
strong correlations can be identified, the generally expected
trends are confirmed. Pocket coverage exhibits a moderate
Fig. 6 NPR shape distribution
by pocket volume bins. Color
code shows the maximal
number of data points per cell
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correlation to activity. Furthermore, distance in NPR shape
space, distance between the centers-of-mass of ligand and
pocket, as well as the angle between the first principal axes
of ligand and pocket ellipsoid show moderate negative
correlation to activity.
These trends become more pronounced when pocket/
ligand pairs are binned into three categories based on their
bioactivity. Significant differences between the distribu-
tions for the previously mentioned pocket parameters—
pocket coverage, NPR distance, centers-of-mass distance,
and ellipsoid angle deviation—can be observed (Fig. 9).
The trends within these data points mirror the respectively
found correlations between the classifiers.
Work from Kuntz [33] and Reynolds [34] assesses the
maximal achievable binding affinity and efficiency of a small
molecule in dependence of its size. Their results show that
maximal binding efficiency flattens off for molecules of
large size which they attribute to enthalpic, entropic, and
geometric reasons. Similarly, we analyzed whether there
might be a possible limitation originating from the size of the
binding pocket. Such information could provide a better
understanding regarding what binding efficiency could be
maximally expected for a given pocket, and hence be an
additional parameter for target druggability assessments.
Here, we use NBEI (=pKi/Number of Heavy Atoms) [35] as
ligand efficiency index. Figure 10a shows for the 355
extracted PDBbind ligands a similar decline of maximal
efficiency with increasing size of the molecule, as has been
found by Kuntz and Reynolds. Figure 10b highlights the
distributions of NBEI with respect to the corresponding
binding pocket volume bins as an alternative size measure. A
similar decrease of efficiency with increasing volume of the
identified pocket can be seen. Above a volume of 1,200 A˚3,
maximal NBEIs observed are significantly lower than in
smaller volume bins. Additionally, the data suggest that
targets containing a binding pocket with a volume between
300 and 700 A˚3 have a higher probability for the identifica-
tion of a highly efficient binder. Focusing on volumes, Liang
et al. [17] describe a similar correlation between ligand and
pocket dimensions, predominately for pocket volumes with
less than 700 A˚3. Generally, value comparisons between
studies are difficult due to differences in the computation.
Furthermore, even when considering several structures of the
same target bound to different ligands, predicted pockets and
their properties vary. In a previous study on druggable
pockets [23], the volumes of 40 p38 kinase ligand binding
sites in different activitation states, predicted with DoGSite,
were found to span a volume range from 450 A˚3 to almost
1,800 A˚3 (pocket, not subpocket values). This clearly shows
the impact of the ligand on pocket shape and volume.
Interestingly, no correlation (R = -0.01) between
NBEI and pocket coverage can be observed, while there
exists a moderate correlation between ligand size as num-
ber of heavy atoms and pocket coverage (R = 0.41).
Incorporating the information that activity has a moderate
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Fig. 8 Coverage-binned distributions of a pairwise ligand and pocket euclidean distance in NPR shape space, b distances between the centers-
of-mass, c angles between the first main ellipsoidal axes of pocket and ligand ellipsoid
Fig. 7 Pocket coverage distribution of pockets and subpockets in sc-
PDB data set
Table 2 Pearson correlation coefficient of activity versus other
pocket parameters
Correlation of activity versus R (Pearson)
Pocket coverage 0.39
Distance NPR ligand/pocket -0.32
Distance centers-of-mass ligand/pocket -0.34
Angle between first principal ellipsoid axes -0.29
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correlation to pocket coverage, it can be concluded that
with rising pocket coverage, activity is enhanced as binding
pocket and ligand complementarity increases. This seems
to be more prevalent for larger ligands, but as binding
efficiency is determined as the ratio between activity and
size, this has no effect on efficiency.
Protein/ligand shape and size comparison in virtual
screening
The capability of different parameters retrieved from per-
ceived binding pockets and corresponding co-crystallized
ligands to identify active molecules is analyzed using a
selected data set of 123,539 compounds from the ChEMBL
database. Four molecular targets [PIM1 (PDB code: 3CY3),
AR (PDB code: 3G0W), p38 (PDB code: 3HRB), VEGFR2
(PDB code: 2QU6)] have been chosen to broadly sample the
binding pocket NPR shape space (Fig. 11).
We compare the effects of five different parameters to
each other regarding early enrichment in virtual screening:
Euclidean distance in NPR shape space between ChEMBL
compounds and co-crystallized ligand or binding pocket,
respectively, absolute volume difference between ChEM-
BL compounds and co-crystallized ligand, absolute
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Fig. 9 Distributions of NPR
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between ellipsoidal main axes
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difference in number of heavy atoms between co-crystallized
ligand and ChEMBL compounds, and absolute compound to
pocket volume ratio distance from a predefined gold standard
value. The absolute volume ratio distance is calculated as
j0:4  compound volume=pocket volumej: The value 0.4 has
been chosen based on the mean values found during the
previous analysis of pocket and subpocket coverage. To
assess active retrieval performance in comparison to ran-
dom, the early enrichment factor (EEF) is determined as
EEFx% ¼ %Activesx%= %Datax%: Figure 12 illustrates the
respective enrichment results at x = 1, 2.5, 5, 7.5, and 10 %
of the data. Corresponding ROC curves and AUCs can be
found in the supplemental material (Figure S1). For the
evaluation of active retrieval performance, we favor EEFs
over AUCs, as in most experiments only a small percentage
of the full dataset will be selected and tested experimentally.
The performance on target p38 is close to random; only for
the 1 and 2.5 % bins a few parameters, e.g., number of heavy
atoms and NPR pocket distance, show higher EEF values
than one. In the example of AR, all parameters, especially
those considering volume differences, show a better
enrichment than what could be expected by chance. For
PIM1, these two volume dependent filters are the only
parameters showing a good enrichment better than random.
In contrast, for VEGFR2, NPR distance to the co-crystallized
ligand clearly outperforms all other studied parameters.
The generally good performance of the ligand-based
filters suggests that shape and size similarity to a reference
ligand, if available, might be a more valuable parameter to
optimize for than a high similarity with the binding pocket,
especially considering NPR shape. Note, that the pocket-
based NPR shape filter performs better for targets with
binding site shapes closer to the center of ligand shape
distribution, e.g., for AR (see Fig. 11). The filter has a
higher probability to fail in cases where the binding site
shape has a large distance to this center of distribution, e.g.,
in the case of PIM1 whose binding pocket shape is located
close to the disc-like corner. While shape similarity based
on distance in NPR shape space is superior in p38 and
VEGFR2, results from PIM1 and AR show a better per-
formance when using the difference in volume instead.
Considering volume or volume ratio distance, the pocket
parameter performance is similar to the ligand-based filter.
This is due to the fact that this volume ratio, although
solely based on the pocket volume, describes the difference
in volume between an on average fitting reference mole-
cule and the compound of interest. Thus, this provides very
valuable information in cases where no reference molecule
is known.
Averaged enrichment factors over all analyzed early
enrichment bins (1, 2.5, 5, 7.5, and 10 %) and targets
showed similar results for absolute volume ratio distance of
compound and binding pocket, NPR distance and volume
difference based on comparison with the co-crystallized
ligand with a factor of 1.7 over random performance.
Difference in the number of heavy atoms and NPR distance
between binding pocket and screened compound perform
worse (average EEF of 1.3 and 1.1, respectively). Although
utilizing the selected parameters as ranking scheme for
compounds results in a better performance than what could
be expected by chance, it is clear that the achieved per-
formance is not sufficient for practical purposes; too many
of the known actives would be missed during experimental
testing. As a comparison, docking experiments against
crystal structures of the four chosen targets are performed
using the Glide HTVS docking engine [31]. By integrating
an elaborated scoring function, an increase in signal over
the previous experiment is to be expected. In general, the
introduction of Glide improves the achieved average EEF
from the average value of 1.5 of the discussed parameters
to 7.4 over all analyzed early enrichment bins (1, 2.5, 5,
7.5, and 10 %) and targets (Table 3).
Three of the selected targets, namely p38, AR, and
VEGFR2, are part of the Directory of useful Decoys
(DUD) [36] and have been analyzed in a benchmark study
by Cross et al. [37]. A mean enrichment factor for all DUD
targets between 13.3 (at 0.5 %) and 3.8 (at 10.0 %) was
reported by Cross et al., which closely resemble the mean
EEFs between 13.5 (at 0.5 %) and 4.1 (at 10.0 %) for the
four targets analyzed in this study.
However, placing and scoring several thousands of
compounds with high precision is a very time-consuming
process. The aim of this analysis is therefore to investigate
whether information on binding pocket and co-crystallized
ligand can be used to pre-filter the data set. Ideally, a filter
increases early retrieval rates of actives by removing
compounds that do not fulfill the requirements of the
molecular target. Generally, decreasing the number of
Fig. 11 Overview on NPR shape space location of the selected
binding pockets of the selected targets
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compounds to screen while achieving constant early
enrichment rates is equally important, as this speeds up the
docking process and requires less computational resources.
Exemplarily, we investigate a reduction of the data set by
one third based on the chosen parameters. When removing
33 % of the compounds based on the chosen parameters
(Fig. 13), early enrichment factors improve for PIM1. The
performance slightly decreases for the two targets, AR and
VEGFR2, when considering NPR shape filters. In contrast,
considering volume and molecular size-based filters, the
performance in AR remains constant, while it slightly
increases for VEGFR2. For p38, enrichment factors
decrease for all tested parameters, particularly for the NPR
based filters. As null hypothesis, we carry out a random
filtering that is removing 33 % of the data in 500 inde-
pendent runs. The resulting DEEFs in Fig. 13 show that all
filters perform better than random, except for target p38, in
which the NPR distance filter based on a reference ligand
does not show an improvement over a random removal of
compounds prior to the virtual screening experiment.
Corresponding ROC curves and AUCs can be found in the
supplemental material (Figure S2).
To summarize, the results show that the introduction of
filters based on molecular or pocket shape and size
properties can aid in decreasing the number of compounds
to screen without distinctly diminishing performance in
active retrieval. The results furthermore suggest that a
molecular size-based pre-filter might be more effective
than a shape-based pre-filter in structure-based virtual
screening. It is a known effect that docking scores can be
correlated with molecular size [38]. We cannot exclude
that this might be the reason for the observed effect in the
performed study. The tested parameters based on ligand
information appear to be more valuable for the pre-filter
application. Nevertheless, a pocket-based filter can be very
useful in screening scenarios, in which no bound reference
ligand is known beforehand. The calculated compound to
pocket volume ratio distance, e.g., mimics the volume
distance of a compound from a potentially binding ligand
under the assumption that the most prominent volume ratio
between bound ligand and pocket lies at 0.4. While this
value has been derived from the previous analysis, it holds
for the four studied targets, in which pocket and ligand
volume ratios evaluate exactly to this value. Also, while we
describe observations for different parameters, it is unclear
whether these results can be extrapolated to other data sets,
targets, pocket prediction algorithms or docking programs.
We are nevertheless convinced that this study gives an idea
on how filters could be usefully integrated into a virtual
screening process.
Conclusion
In this study, a comparison between shapes of protein
binding pockets and their corresponding ligands using the
NPR shape description is presented. The experiments
within this study are performed on predicted subpockets
Fig. 12 Early Enrichment (%Actives against %Data screened) for
p38 (3HRB), Androgen receptor (3G0W), PIM1 (3CY3) and VEG-
FR2 (2QU6). Volume ratio difference between pocket and screened
compound (turquoise). NPR distance between pocket (red)/reference
ligand (blue) and screened compound. Volume difference between
reference ligand (green) and screened compound. Difference in
Number of Heavy Atoms between reference ligand and screened
compound (purple)
Table 3 Early enrichment factors (EEF) by glide for the selected
targets
Target EEF1% EEF2.5% EEF5% EEF7.5% EEF10%
p38 [3HRB] 19.9 10.6 6.6 4.9 4
AR [3G0W] 19.6 11.4 7.7 5.6 4.5
VEGFR2 [2QU6] 8.9 5.6 3.8 3.1 2.8
PIM1 [3CY3] 5.6 6.7 6.0 5.4 5.0
522 J Comput Aided Mol Des (2013) 27:511–524
123
(although the term pocket is used throughout the study),
which provide a finer description of a cavity. Similarly to
what has been reported for small molecule data sets of
various origins, we observe an absence of truly spherical
ligand and binding pockets in our stringently selected data
set of 2,363 pocket/ligand pairs from the sc-PDB. Con-
trarily, globular pockets are prevalent when considering all
detectable pockets within protein structures, particularly
for pockets of small volume. Furthermore, when consid-
ering pockets (not subpockets), it could be seen that on
average the ligand covers one third of the pocket. This is in
accordance with findings from Kahraman et al. [4] on a less
diverse data set. Subpockets show on average a higher
coverage (50 %), underlining the information gain due to
the more fine-granular description. Thus, this study
broadens the knowledge about the importance of shape
complementary for complex formation. A clear decrease of
three analyzed parameters with increasing pocket coverage
can be observed: The average shape distance is found to be
below 0.2 in NPR space, the centers-of-mass distance of
the respective ellipsoids is below 2.4 A˚, and the angle
between the largest ellipsoidal main axes deviates less than
29. While it is difficult to provide gold standard values,
due to different implementations of pocket detection
algorithms and ways to compute features thereof, in our
opinion, these results provide a very valuable starting point
for further research.
With respect to exhibited bioactivity, tested on a PDB-
Bind subset, only a moderate correlation with pocket
coverage is observed, which illustrates the importance of
other complementing factors. However, when binning
active compounds into three classes by their strength of
interaction, it was found that high affine binders tend to
possess a higher shape complementarity and cover on
average more than two thirds of the binding pocket. Also,
their corresponding molecular shapes are significantly
more strongly aligned. Contrarily, low-affine binders
exhibit a larger flexibility in their shape congruence to the
binding site. With respect to ligand efficiency, this article
discusses to which extent pocket size influences the max-
imal achievable ligand efficiency. The data suggest that
pockets with a volume smaller than 700 A˚3 have an
increased probability of fitting a highly efficient binder.
Although these findings need to be investigated further and
the value is dependent on the pocket identification method
used, this provides a very interesting starting point into the
investigation of pocket druggability. Clearly, maximal
achievable binding efficiency cannot only be related to the
size of a small molecule but also to features present in the
corresponding binding site.
This article furthermore investigates whether it is possible
to use information on binding pocket volume and shape to
filter out compounds a priori in a large-scale virtual screen-
ing campaign. The hypothesis is that such a step might
increase the hit rate of the screen by preferentially removing
inactive compounds and simultaneously decreasing the
number of compounds to be screened. With regards to the
ever-increasing number of compounds available for virtual
Fig. 13 Differences for p38 (3HRB), Androgen receptor (3G0W),
PIM1 (3CY3), and VEGFR2 (2QU6), respectively, in early enrich-
ment factors to the original Glide enrichment factor (Table 3) when
filtering 33 % of the data based on the given parameters. For
comparison, results of a random 33 % filter are presented. Bars
represent the mean, lines the standard deviation of results from 500
independent runs
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screening and with the introduction of more sophisticated
calculations, the reduction of compound sets is of high
interest. As can be seen on the four selected examples, using
the provided filters reduces the number of compounds by one
third, while achieving mostly stable early enrichment rates.
Filters making use of information extracted from known
reference molecules show generally a good performance.
Nevertheless, using pocket information, especially if no
reference ligand is known, enables a new set of filters
applicable in structure-based virtual screening.
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